Cognito Therapeutics Stock

www.cognitotx.com/HealthcareFounded: 2016

Cognito Therapeutics is a developer of a pipeline of disease-modifying digital therapeutics intended to cure neurodegenerative disorders. The company's therapies aim to use induced brain wave oscillations to treat Alzheimer's by reactivating the immune system in the brain, enabling patients to reduce typical hallmarks of the disease like amyloid plaques and tau tangles.

Register for Details

For more details on financing and valuation for Cognito Therapeutics, register or login.

Please provide a valid email address.

By registering, you agree to Forge’s Terms of Use. Already registered? Log in

Enterprise Value (based on primary financings)

Powered by Forge Data
Enterprise Value

View Enterprise Value for Cognito Therapeutics.

Register Today

Cognito Therapeutics investors also invested in these private companies

Morningside Group
FoundersX Ventures
Starbloom Capital
IAG Capital Partners
Alzheimers Drug Discovery Foundation
Wilson Sonsini Goodrich & Rosati

Team

Management Team

Brent Vaughan
Chief Executive Officer
Zach Malchano
President & Chief Research & Development Officer
Mihaly Hajos
Chief Scientific Officer
Li-Huei Tsai Ph.D
Co-Founder
Ralph Kern MD
Chief Medical Officer
Jonathan Lieber
Chief Financial Officer
Everett Crosland
Chief Commercial Officer
Edward Boyden Ph.D
Co-Founder

Board Members

Stephen Bruso
Morningside Group

Other companies like Cognito Therapeutics in the Healthcare sector

Sector
Last Round Est. Valuation
$3.67B
Sector
Last Round Est. Valuation
$809.52MM
Sector
Last Round Est. Valuation
$1.01B
Sector
Last Round Est. Valuation
$4.26B
Sector
 
 
Sector
Last Round Est. Valuation
$396.01MM
Sector
Last Round Est. Valuation
$400.53MM
Sector
Last Round Est. Valuation
$1.53B